https://www.selleckchem.com/pr....oducts/xl413-bms-863
r PR+ and HER2-/+ showed poorer prognosis than the other 2 levels. Risk factor grouping based on the ER, PR, HER2, Ki-67 status, tumor grade, and lymph nodes postsurgery showed that patients in highest score group received the poorest prognosis. Grading system based on the hormone status or the risk factor grouping may offer a useful approach to assess which subgroups of young breast cancer present poorer prognosis. Healthcare professionals have negative implicit biases toward minority and poor patients. Few communication skill
Мне нравится
Комментарий
Перепост
